Summit Shares Soar After Cancer Drug Tops Merck’s Keytruda
(Bloomberg) -- Summit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its goal in patients with non-small cell lung cancer. Most Read from Bloomberg The Miami-based company said that its drug, ivonescimab, showed “a …